Skip to main content

Advertisement

Log in

Effect of Thymalin on the Tumor and Thymus under Conditions of Activation Therapy In Vivo

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Pronounced antitumor effect of Thymalin in doses lower than the therapeutic doses was shown in experiments on albino outbred male rats with transplanted sarcoma 45. Tumor growth arrest and its regression were observed in more than half of animals and in other cases, the growth was suppressed by 78%. Microstructural changes in the thymus were analyzed. Significant increase in lymphoproliferative activity and the content of tissue basophils and plasmocytes in the thymus lobules was observed. Tumor regression was accompanied by the development of stable antistress adaptation reactions of calm and elevated activation. High efficiency of Thymalin can be attributed to the use of lower doses of the substance and their modulation during the treatment course in accordance with the regimes of activation therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Anisimov VN, Khavinson VKh. The use of peptide bioregulators for cancer prevention: results of 35 years of research experience and perspectives. Vopr. Onkol. 2009;55(3):291-304. Russian.

    PubMed  CAS  Google Scholar 

  2. Arion VYa, Zimina IV, Moskvina SM. Immunobiology and clinical application of thymosin and other thymic preparations. Immunopatol., Allergol., Infektol. 2008;(1):26-40. Russian.

    Google Scholar 

  3. Garkavi LKh, Kvakina EB, Kuz’menko TS, Shikhlyarova AI. Antistress Reactions and Activation Therapy. Part I. Ekaterinburg, 2002. Russian.

  4. Zamorskii II, Shchudrova TS, Lin’kova NS, Nichik TE, Khavinson VKh. Peptides Restore Functional State of the Kidneys During Cisplatin-Induced Acute Renal Failure. Bull. Exp. Biol. Med. 2015;159(6):736-739.

    Article  PubMed  CAS  Google Scholar 

  5. Zinchenko SV. Immunomodulators in complex therapy of oncological patients (review of the literature). Povolzh. Onkol. Vestn. 2014;(1):57-64. Russian.

    Google Scholar 

  6. Krasovskii GN, Rakhmanin TA, Egorova NA. Extrapolation of Animal Toxicity Data to Humans. Moscow, 2009. Russian.

  7. Novoseletskaya AV, Kiseleva NM, Zimina IV, Belova OV, Inozemtsev AN, Arion VY, Sergienko VI. Stress-protective effect of thymic peptides. Bull. Exp. Biol. Med. 2015;158(6):753-755.

  8. Khavinson VKh, Malinin VV, Vanyushin BF. Role of peptides in epigenetic regulation of gene activities in ontogeny. Bull. Exp. Biol. Med. 2012;152(4):470-474.

    Article  PubMed  Google Scholar 

  9. Khavinson VK, Ryzhak GA. Peptide regulation of the body’s main functions. Vestn. Roszdravnadzora. 2010;(6):58-62. Russian.

    Google Scholar 

  10. Chervyakova NA, Linkova NS, Chalisova NI, Koncevaya EA, Trofimova SV, Khavinson VKh. Molecular aspects of immunopritective activity of peptides in spleen during the aging process. Uspekhi Gerontol. 2013;26(2):224-228. Russian.

    Google Scholar 

  11. He SH. Key role of mast cells and major secretory products in Inflammatory bowel disease. World. J. Gastroenterol. 2004;10(3):309-318.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Kit OI, Shikhlyarova AI, Zhukova GV, Maryanovskaya GY, Barsukova LP, Korobeinikova EP, Sheiko EA, Protasova TP, Evstratova OF, Barteneva TA, Salatov RN, Sergostiants GZ, Atmachidi DP. Activation therapy: theoretical and applied aspects. Cardiometry. 2015;(7):22-29. doi: https://doi.org/10.12710/cardiometry.2015.7.2229.

  13. Murray PR, Rosenthal KS, Pfaller MP. Elements of Host Protective Responses. Medical Microbiology. Philadelphia, 2013:33-44.

  14. Wolf E, Milazzo S, Boehm K, Zwahlen M, Horneber M. Thymic peptides for treatment of cancer patients. Cochrane Database Syst. Rev. 2011;(2):CD003993. doi: https://doi.org/10.1002/14651858.CD003993.pub3.

    Article  Google Scholar 

  15. Zhukova GV, Shikhliarova AI, Soldatov AV, Barteneva TA, Petrosian VI, Gudtskova TN, Bragina MI, Polozhentsev OE, Sheiko EA, Maschenko NM, Shirnina EA, Zlatnik EY, Kurkina TA. Some approaches to the activation of antitumor resistance mechanisms and functional analogs in the categories of synergetics. Biofizika. 2016;61(2):359-373.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to G. V. Zhukova.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 165, No. 1, pp. 94-98, January, 2018

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhukova, G.V., Schikhlyarova, A.I., Barteneva, T.A. et al. Effect of Thymalin on the Tumor and Thymus under Conditions of Activation Therapy In Vivo. Bull Exp Biol Med 165, 80–83 (2018). https://doi.org/10.1007/s10517-018-4104-z

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-018-4104-z

Key Words

Navigation